JOSIE JOY BALBOA-AZURA: Open Payments
NPI 1407226285 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 53 payments from 14 companies in 2025. Trend: 2023 $992 · 2024 $1,585 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 7 | $465 |
| Travere Therapeutics, Inc. | 7 | $171 |
| Vantive US Healthcare LLC | 2 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Calliditas Therapeutics US Inc. | 4 | $89 |
| Amgen Inc. | 3 | $85 |
| Ardelyx, Inc. | 3 | $58 |
Products named: Vafseo, Kerendia, JYNARQUE, JARDIANCE, TARPEYO, KRYSTEXXA, IBSRELA, FARXIGA.
Industry payments across AZ — which companies pay providers there.
